(Q42511904)

1 November 2017

Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact (English)

1 reference

1 November 2017

1 reference

8

Ingrid Hedenfalk

1 reference

1 November 2017

Cecilia Nilsson

1

1 reference

1 November 2017

Ida Johansson

2

1 reference

1 November 2017

Cecilia Ahlin

3

1 reference

1 November 2017

Sten Thorstenson

4

1 reference

1 November 2017

Rose-Marie Amini

5

1 reference

1 November 2017

Marit Holmqvist

6

1 reference

1 November 2017

Leif Bergkvist

7

1 reference

1 November 2017

Marie-Louise Fjällskog

9

1 reference

1 November 2017

29 August 2012

1 reference

1 November 2017

1 reference

1 November 2017

52

1 reference

1 November 2017

1

1 reference

1 November 2017

102-109

1 reference

Incidence and outcome of male breast cancer: an international population-based study.

1 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Gene expression profiling in breast cancer: classification, prognostication, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Breast cancer subtypes and the risk of local and regional relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Breast carcinoma in men: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Immunohistochemical characterization of subtypes of male breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Molecular subtyping of male breast cancer by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Carcinoma of the breast in males: a multiinstitutional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Status of HER-2 in male and female breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Her-2/neu gene amplification and protein expression in primary male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

Expression of cell cycle proteins in male breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2012.711952

10.3109/0284186X.2012.711952

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference